“…The exact mechanism behind the induction of autoimmunity by IFN-b in MS patients is unknown (Durelli et al, 1998;Pulicken et al, 2006). PBC may have remained subclinical, although fatigue was present in this patient, which, in hindsight could have also been related to PBC (Bhandari et al, 2011). The long-term use of IFN-b may have aggravated the presumed pre-existing PBC, triggering the elevations in ALT and AST, appearing as autoimmune hepatitis.…”